NASDAQ:AMTX Aemetis (AMTX) Stock Price, News & Analysis $2.62 -0.07 (-2.60%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Aemetis Stock (NASDAQ:AMTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aemetis alerts:Sign Up Key Stats Today's Range$2.60▼$2.8450-Day Range$2.62▼$4.6252-Week Range$2.10▼$7.03Volume1.05 million shsAverage Volume796,085 shsMarket Capitalization$130.31 millionP/E RatioN/ADividend YieldN/APrice Target$12.95Consensus RatingModerate Buy Company OverviewAemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.Read More… Aemetis Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks30th Percentile Overall ScoreAMTX MarketRank™: Aemetis scored higher than 30% of companies evaluated by MarketBeat, and ranked 222nd out of 272 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingAemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAemetis has only been the subject of 1 research reports in the past 90 days.Read more about Aemetis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aemetis are expected to grow in the coming year, from ($2.02) to ($0.59) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aemetis is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aemetis is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.78% of the outstanding shares of Aemetis have been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in Aemetis has recently decreased by 3.25%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAemetis does not currently pay a dividend.Dividend GrowthAemetis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.78% of the outstanding shares of Aemetis have been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in Aemetis has recently decreased by 3.25%, indicating that investor sentiment is improving. News and Social Media0.9 / 5News Sentiment-0.47 News SentimentAemetis has a news sentiment score of -0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Aemetis this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aemetis insiders have not sold or bought any company stock.Percentage Held by Insiders15.90% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.02% of the stock of Aemetis is held by institutions.Read more about Aemetis' insider trading history. Receive AMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter. Email Address AMTX Stock News HeadlinesAemetis: I Have Serious ConcernsDecember 19 at 2:01 AM | seekingalpha.comAemetis Registrations Approved by the IRS for 45Z Production Tax CreditsDecember 17, 2024 | finance.yahoo.comTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… December 22, 2024 | Crypto 101 Media (Ad)Aemetis, Inc. (NASDAQ:AMTX) Given Consensus Rating of "Moderate Buy" by BrokeragesDecember 12, 2024 | americanbankingnews.comAemetis Biogas Starts Production From Tenth Dairy Digester With Additional Digesters in Final Stages of Commissioning and ConstructionDecember 10, 2024 | markets.businessinsider.comAemetis Biogas starts production from tenth dairy digesterDecember 10, 2024 | markets.businessinsider.comAemetis subsidiary in India completed delivery of $103M of biodiesel to OMCsDecember 4, 2024 | markets.businessinsider.comAemetis India Completes $103 Million of Biodiesel Deliveries to OMCs in 2024 and Receives Initial $58 Million Allocation for the 2025 Marketing YearDecember 3, 2024 | finance.yahoo.comSee More Headlines AMTX Stock Analysis - Frequently Asked Questions How have AMTX shares performed this year? Aemetis' stock was trading at $5.24 at the beginning of the year. Since then, AMTX shares have decreased by 50.0% and is now trading at $2.62. View the best growth stocks for 2024 here. How were Aemetis' earnings last quarter? Aemetis, Inc. (NASDAQ:AMTX) released its quarterly earnings results on Tuesday, November, 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.09. The specialty chemicals company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. Who are Aemetis' major shareholders? Top institutional shareholders of Aemetis include Geode Capital Management LLC (1.86%), State Street Corp (1.41%), Stifel Financial Corp (0.84%) and Charles Schwab Investment Management Inc. (0.18%). Insiders that own company stock include Naomi Louise Boness and John R Block. View institutional ownership trends. How do I buy shares of Aemetis? Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Aemetis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings11/12/2024Today12/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorOils/Energy Industry Industrial organic chemicals Sub-IndustryChemicals Current SymbolNASDAQ:AMTX CUSIPN/A CIK738214 Webwww.aemetis.com Phone(408) 213-0940Fax408-252-8044Employees160Year FoundedN/APrice Target and Rating Average Stock Price Target$12.95 High Stock Price Target$28.00 Low Stock Price Target$3.50 Potential Upside/Downside+394.3%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($2.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-46,420,000.00 Net Margins-33.21% Pretax Margin-32.43% Return on EquityN/A Return on Assets-40.11% Debt Debt-to-Equity RatioN/A Current Ratio0.26 Quick Ratio0.11 Sales & Book Value Annual Sales$291.40 million Price / Sales0.45 Cash FlowN/A Price / Cash FlowN/A Book Value($5.49) per share Price / Book-0.48Miscellaneous Outstanding Shares49,735,000Free Float41,827,000Market Cap$130.31 million OptionableOptionable Beta1.35 Social Links 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:AMTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aemetis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.